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Abstract
The dire state of the COVID-19 pandemic crisis symbolized the urgency for efficient
distribution and administration of vaccines to combat the virus as the most urgent
public health service. This paper presents a prototype multi-criteria decision support
model based on goal programming that can effectively support vaccination plans for
the greater good of society. The optimization goals of the model include minimizing the number of fatalities and risk of spreading the disease, while complying with
government health agency’s priority guidelines for vaccination. This study applied
the model to a real-world dataset to demonstrate how it can be effectively applied as
a decision support tool for vaccine distribution plans and manage future pandemics.
Keywords COVID-19 · Vaccine distribution priorities · Multiple-objective decision
modeling · Goal programming · Decision support systems

1 Introduction
In December 2020, the United States Food and Drug Administration (FDA)
approved the emergency use authorization of the two leading COVID-19 vaccines produced by Pfizer/BioNTech (Lovelace Jr. 2020) and Moderna (Miller and
Edwards 2020). A third vaccine produced by Johnson & Johnson was approved for
distribution in February 2021 (Fda.gov 2021). These authorizations consist of a historic turning point in the fight against the pandemic that has taken more than one
million lives in the US and about 6.3 million worldwide as of May 2022 (Johns
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Hopkins University 2022). While vaccine administration is now well underway in
many countries, the pandemic is far from under control. In addition, new variants of
the virus require the development and distribution of additional booster shots. Many
developing countries around the world are still waiting for the supply of vaccines
from developed nations. Thus, it is important to design an effective decision model
for rapid vaccine distribution based on management science, “the ubiquitous science
of better” (Nikolopoulos et al. 2021), to lower the number of deaths, manage hospital capacity, and return to a near normal state soon.
In the US, the center for disease control and prevention (CDC) and other agencies established vaccine distribution priorities. In the first phase, healthcare workers and residents at long-term care facilities had the top priority to receive the vaccine (Gillespie 2020). Once the first phase of vaccination is completed, the next step
would be to prioritize and deliver to the general population. Such delivery is not
on a “first-come, first-served” basis. Instead, healthcare practitioners and state officials must provide the vaccines among the various priority groups to satisfy multiple objectives, such as minimizing the time required to vaccinate the entire eligible
population, minimizing mortality, and underutilizing hospital capacities (CDCMMWR 2020). This study was motivated by the overwhelming danger of the global
pandemic. COVID-19 has completely disrupted the daily lives of almost everyone in
the world. This is the reason why the effective management of vaccine distribution
is such an urgent public service issue, the very motivation for this study.
The authors communicated with representatives from several sectors that are
involved in vaccine distribution planning: two professors at noted medical schools
(a clinician/academic physician and a public health faculty), two newspaper editors/
reporters who have developed objective macro views on COVID-19 based on their
frequent contacts with government and public health decision-makers, and government policy makers at the Ministry of Health and Public Policy in a European country. The discussion with the above experts and opinion leaders provided first-hand
knowledge about the challenges of the COVID-19 vaccination program. Specifically, these experts provided the assurance that there is a need for a decision support
model that can apply administration priorities based on important factors that are
relevant at a given time (virus spread phase) or place (country, city, county, etc.).
In addition, the decision support tool should be able to help attain multiple goals:
reduce the mortality rate, minimize the number of new infections, and achieve herd
immunity as soon as possible. Finally, the decision-making model should be able to
address not only current vaccine distribution-related issues, but also be able to help
with possible future challenges such as expected booster shots and new variant vaccines, and even preparing for inevitable future pandemics.
The current CDC guidelines imply that age, medical conditions, and occupation (e.g., frontline or essential workers) (AMO) are important health factors in
the fight against the COVID-19 pandemic, in addition to other measures such as
wearing masks, physical distancing, and avoiding crowds. While older people are
more vulnerable to the disease and have a higher risk of death, so are people with
prior medical conditions. Concurrently, certain segments of the population, such
as school children and essential workers, have a significant role in controlling the
spread of COVID-19. CDC believes that the current vaccination priorities among
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these population segments would be effective in lowering death rates, minimizing
the risk of spreading the virus, minimizing overutilization of healthcare facilities,
and achieving herd immunity soon. This paper offers answers to what population
subgroups must be vaccinated to: (1) comply with CDC and state guidelines, (2)
avoid the risk of spreading the disease, and (3) minimize the number of individuals
that will succumb to the disease. In this paper, a prototype goal programming (GP)
model is developed which combines the above three criteria to allow the decisionmaker to effectively assign different priorities to population subgroups that need to
be vaccinated.
The rest of the paper is organized as follows. In the next section a review of relevant literature is provided, including COVID-19 as the most destructive pandemic
in the global age and vaccine distribution strategies, as well as properties and previous application studies of GP in the healthcare industry. Then, a prototype GP model
is developed using the age, medical condition, and economic function as population
classification criteria. In Sect. 3, the proposed GP model using a real-world COVID19 dataset from kaggle.com is presented. Finally, in the discussion section, the significance of the study and its implications are elaborated; then recommendations
based on the findings to public health policy makers, healthcare practitioners, and
state officials are provided; and the paper concludes with limitations of the study
and future research directions.

2 Literature review
2.1 The COVID‑19 pandemic
The onslaught of COVID-19 is not just one destructive wave, but repeated flareups as witnessed in many countries (Daly and Rolander 2021). The waves of virus
resurgence and new variants are threatening the hope of speedy recovery from the
destructive force of the pandemic. Recently, several countries reintroduced economic lockdowns due to the resurgence of COVID-19 cases resulting from new variants (Leatherby 2021). Thus, governments, scientists, businesses, and communities
around the world are trying to find the best approaches to contain the virus in order
to return to normality as soon as possible (Devezas 2020).
The two important approaches to managing the pandemic involve the following:
(1) preventing the spread of the virus and controlling virus resurgence through sound
government directives and tracking (Lee and Trimi 2021; Sainz-Pardo and Valero
2021), while concurrently developing effective vaccines and rapidly administering them to the population for reaching herd immunity; and (2) managing infection
cases by finding right treatment methods and cures. For the first approach, implementing sound practices recommended by credible agencies such as CDC, as well as
a set of directives issued by the federal government and further reinforced by state/
local governments, is imperative. Advanced technologies such as artificial intelligence (AI), internet of things (IoT), big data analytics, virtual/augmented reality
(VR/AR), blockchain, 3-D printing, smart sensors and robots, and mobile location
systems have been innovatively applied to learning about the virus (for treatment

13

A. Asllani, S. Trimi

and vaccination) and containing its spread (tracking and civic behavior) (Brem et al.
2021; Martin and Yoon 2020; Nigma et al. 2021).
2.2 COVID‑19 vaccine distribution strategies
The obvious best solution to managing the pandemic is to vaccinate a sufficient proportion of the population, in addition to those who were infected and recovered, to
develop herd immunity. Although there exists no exact percentage of the population
that need to be vaccinated to achieve herd immunity, as the exact number of people who already had the virus is not known, the scientific community estimates that
58–94 percent of 18 + age group would need to be vaccinated (Apple et al. 2020).
Undoubtedly, delivering billions of vaccine doses globally is one of the greatest
logistical challenges ever undertaken, in addition to the economic aspects of the vaccine development. During the early stages of the vaccination program, demand for
vaccine is expected to exceed supply. Thus, countries need to develop priority lists
of vaccine recipients, which are based on common factors of age, medical conditions, and jobs (healthcare providers, front liners, etc.). The advisory committee on
immunization practices (ACIP) in the US recommended the priority list based on
scientific evidence regarding COVID-19, ethical principles, and vaccination program logistics considerations (CDCMMWR 2020).
2.3 Multiple‑objective decision‑making models with GP
There have been several well-known management science methods for multipleobjective decision-making. Goal programming (GP) is one of the most widely
applied solution techniques for decision problems that involve multiple and conflicting objectives. GP represents a special case of mathematical programming techniques, which can be used to achieve optimal satisficing solutions for multiple goals.
The concept of GP was first introduced by Charnes et al. (1955). The solution algorithm of GP and its first use as a decision analysis tool were described in the seminal works by Lee (1972). Ignizio (1976) and Romero (1991) further explored extensions of GP. Schniederjans (1995) provided an overview of GP models, relationships
between GP and other management science techniques, practical recommendations
for GP model formulations and solutions, as well as a comprehensive bibliography
of GP-related studies. Jones and Tamiz (2002) presented an annotated bibliography
of GP applications and wrote a textbook (Jones and Tamiz 2010) with a specific
focus on the practical applications of GP models. More recently, Colapinto et al.
(2017) provided a comprehensive state-of-the-art review of GP applications in engineering, management, and social sciences.
GP models have been successfully used to improve perishable inventory management (Kendall and Lee 1980a) and better optimize healthcare resources (Jones
and Tamiz 2010). Other studies that inspired this work include minimizing the stay
in surgical patient wait-lists (Arenas et al. 2002), prioritizing subgroups during
vaccine distribution programs (Hovav and Herbon 2017), optimizing the eradication of Ebola (Yu et al. 2015), a multidisciplinary approach for controlling global
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infectious diseases (Silal, 2021), and managing perishable medical resources such as
blood (Kendall and Lee 1980b). In this paper, the popular Excel’s Solver was used
to solve the proposed GP model. This study also used the methodologies proposed
by Asllani and Lari (2015) and Asllani and Halstead (2015) that applied 0–1 GP
models to reach various customer segments based on “recency–frequency–monetary
value” (RFM) marketing approaches.

3 Developing a GP model
3.1 Population segmentation for vaccine distribution
Medical research considers age to be an especially important risk factor for contracting and recovering from COVID-19 (Davis et al. 2020). The CDC guidelines
indicate that the risk for severe illness from COVID is much higher for people in
their 60 s or older than those in their 40 s or 50 s (CDC 2020). Data support these
claims—the top 30 countries with the largest percent of infections and especially
deaths were countries that have older population (eur.who.int). Adults over 65 years
of age represent 80% of hospitalizations and have a 23-fold greater risk of death
than those under 65 (Muller et al. 2020). While people who are 65 years of age
or younger and without underlying preexisting conditions have very small risks of
COVID-19 death, even in pandemic epicenters (Ioannidis et al. 2020).
For this paper, the cutoff points were used to assign individuals into various age
segments, as shown in Table 1. Studies indicate that individuals under 50 years of
age are mostly asymptomatic to COVID (Jung et al. 2020; Spiegelhalter 2020); thus,
they have low mortality risk. However, because this group carries the virus unknowingly most of the time, they also have the highest risk of infecting other people (Pollock and Lancaster 2020). Other age groups are considered less risky for spreading
the virus since they usually show symptoms, and as such, are more likely tested and
if necessary are quarantined.
Table 2 shows the cutoff points regarding the number of medical conditions. The
conditions used in this study include diabetes, COPD, asthma, hypertension or other
cardiovascular conditions, or obesity. In the first group, we placed people with no
prior conditions. In the second group, those individuals with one or two conditions
from the above list were placed, and so on. Data show that people with severe conditions have higher mortality rates (Kim et al. 2020). For example, 8 out of 10 deaths
are for individuals with at least one condition, especially those with cardiovascular

Table 1  Population groups by
age

Age

A-score

Mortality risk

Spread risk

0–49

1

Low

High

50–64

2

Average

Average

65–74

3

High

Low

75 and above

4

Very high

Very low

13

A. Asllani, S. Trimi
Table 2  Population groups by
medical conditions

Number of medical
conditions

M-score

Mortality risk

Spread risk

0

1

Very low

Average

1–2

2

Low

Average

3–4

3

Average

Average

5–6

4

High

Average

7 or more

5

Very high

Average

disease, hypertension and diabetes, and other chronic underlying conditions (euro.
who.int 2020). There is no indication that either group has a higher risk of spreading
the virus. As such, it was assumed that they all spread the disease at the “average”
level.
Table 3 describes four groups of individuals according to their profession and
their impact on the economy. Essential workers are those who conduct operations
and services that are critical to continue operations and activities of critical infrastructure (healthcare; law enforcement, public safety, first responders; food and
agriculture; energy; etc.) (Rho et al. 2020). The essential workers group exhibits the
highest risk level for both getting infected and spreading the virus to the rest of the
population. The other three groups are as follows: at-home individuals with a very
low risk of spreading the virus, those who work from home but occasionally visit
the workplace with a low risk of spreading the virus, and students and teacher who
have a high risk of spreading the disease. An “average” mortality risk was assigned
to each group.
3.2 Priorities for the vaccination campaign
Ideally, when a sufficient amount of vaccine is available and there is no urgency to
reach the herd immunity level, vaccination priorities must be assigned based on the
A-score, M-score, and O-score illustrated in the previous section. The groups with
a higher score should be vaccinated first. However, this order may not be feasible
when demand exceeds supply or if the vaccination program changes its goals or priorities. Under such system constraints, the vaccination campaign goal would be to
decide which subgroups to vaccinate at any given time to achieve the priority goals.
The following general priorities were incorporated in the prototype model:

Table 3  Population groups by
occupation
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Occupation

O-score

Mortality risk

Spread risk

At home individuals

1

Average

Very low

Online workers

2

Average

Very low

Students and teachers

3

Average

Average

Essential workers

4

Average

Very high

COVID‑19 vaccine distribution: exploring strategic…

• P1 = Comply with CDC and state guidelines for vaccinating based on certain age,

medical condition, and occupation groups at a given time.

• P2 = Minimize the spread of the virus to avoid overutilization of hospital capaci-

ties

• P3 = Minimize the mortality rate among COVID infected individuals.

The values of P1, P2, and P3 illustrate the relative importance of these priorities.
The set of priorities can be based on preemptive weights (i.e., P1 >  >  > P2 >  >  > P3)
or on numerical weights. The relative importance of the priorities, either in terms of
preemptive or numerical weights, can be assessed by healthcare experts and vaccination campaign managers. These priorities may need to be modified overtime
as the pandemic mitigation conditions change such as the increased availability of
FDA-approved vaccines, new variants of the virus that extend the capacity of the
healthcare sector to a breaking point, the waning patience of people with COVIDassociated restrictions, and the like.
Since it may not be possible to reach all the goals simultaneously, a set of penalties associated with not achieving the goals should be established. The penalty values would depend on the importance of reaching goals for different population segments. A new set of variables s1, s2, and s3 can be created to represent the failure to
meet each goal and the model can seek to minimize these variables accordingly. The
important characteristic of the proposed GP model for COVID vaccine distribution
is its robustness which accommodates modifications of goal priorities, variables,
and parameters based on the changing environmental conditions.

3.3 Model formulation
3.3.1 Notations of the optimization models
i = 1… A—an index used to identify the individuals in a given age group (A-group).
j = 1… M—an index used to identify individuals in a given medical condition
group (M-group).
k = 1… O—an index used to identify the individuals in a given economic impact
group (O-group).
Nijk—number of individuals who are in A-group i, M-group j, and O-group k.
N—the population size, where:

N=

A M O
∑∑
∑

Nijk

i=1 j=1 K=1

rijk—the risk of infection, or the average number of new infections that an individual in A-group i, M-group j, and O-group k can cause if not vaccinated.
dijk—the mortality rate of individuals who are in A-group i, M-group j, and
O-group k.
V—the number of available vaccines.
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3.3.2 Decision variables
Let the decision variables be 0–1 unknown variable as follows:
xijk = 1 if individuals in A-group i, M-group j, and O-group k are vaccinated; 0,
otherwise

Minimize Z = P1 s−1 + P2 s+2 + P3 s+3

(1)

subject to:
A M O
∑∑
∑

Nijk xijk + s−1 − s+1 = 0 i ∈ {1...A}, j ∈ {1...M}, k ∈ {1...O}

(2)

i=1 j=1 k=1

A M O
∑∑
∑

rijk Nijk (1 − xijk ) + s−2 − s+2 = 0

(3)

i=1 j=1 k=1

A M O
∑∑
∑

dijk xijk + s−3 − s+3 = 0

(4)

i=1 j=1 k=1

A M O
∑∑
∑

Nijk xijk ≤ V

(5)

xijk = 0 or 1, ∀i, j, k

(6)

s+p ≥ 0, s−p ≥ 0 where p = 1, 2, or 3

(7)

i=1 j=1 k=1

Equation (1) is the objective function. It seeks to minimize the deviational var 3. For
iable s−1 , s+2 , and based on previously established priorities P s+3 1, P2, and P
example, if P1 = 1, P2 = 5, and P3 = 10, then the model will first minimize s+3 as
such ensuring the minimization of mortality rate is given the top priority (with
priority 10), then the model will minimize s+2 to ensure the number of new infections remains low (with priority 5). Finally, the model will minimize s1− ensuring
that required subgroups are vaccinated (with priority 1).
Equation (2) is a deviational constraint and represents the vaccination requirement of certain population subgroups. For example, at any given time, the decision-maker must ensure that individuals above a certain age or individuals with a
certain number of medical conditions must be vaccinated as required by CDC or
state guidelines. Thus, the right-hand side (RHS) value represents the number of
people that belong to certain age and medical conditions that must be vaccinated
according to the CDC guidelines, while the triple summation on the left side of
the equation represents the number of people from these subgroups who are vaccinated. By minimizing the negative deviation s1− (seeking to achieve s1− = 0),
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the model seeks to maximize this number of individuals from these subgroups
who receive the vaccine.
Equation (3) represents the risk of spreading the virus. If xijk = 1, then individuals in A-group i, M-group j, and O-group k are vaccinated, as such the risk of
infections is zero (1 − xijk = 0). Otherwise, the risk of spreading the disease is rijk.
By minimizing the positive deviation s2+ and possibly making it zero, the model
seeks to suggest a solution that will minimize the spread of the virus. Equation (4) is also a deviational constraint that represents the mortality rate. By minimizing the positive deviation s+3 and possibly making it zero, the model seeks a
solution that will minimize the mortality rate. Equation (5) is a system constraint
that ensures that the sum of the vaccines assigned to each A-group i, M-group
j, and O-group k does not exceed the number of available vaccines (V). Finally,
Eq. (6) enforces binary values to the decision variables (xijk), and Eq. (7) enforces
non-negativity values to the positive deviational variables (sp+) as well as negative deviational variables (sp−).

4 Results
4.1 Descriptive analytics for population segments
This study used a dataset of 545,760 individual records from kaggle.com (Mukherjee 2020) to illustrate the proposed prototype model. Among other variables, this
dataset has information about age, medical conditions, and whether the individual
survived the Covid-19 infection or not. We used that information to calculate the
number of individuals in each A-group i and M-group j. The data file, however, does
not contain any records on the occupation; therefore, we used general demographics
(Rho et al. 2020) to assign individuals in O-group k.
Tables 4, 5, and 6 summarize information for age, medical conditions, and occupation group, respectively. Table 4 organizes the population sample based on agecutoff suggested in Table 1. Thus, the first row represents all individuals from 0
to 49 years old, and for identification purposes, A-score of 1 was assigned to this
group. Because it is assumed, as previously discussed, that this group is most likely
to spread the virus (since they are mostly asymptomatic), the highest risk score of

Table 4  Descriptive analytics
based on age

Age cutoff

A-score

Risk of spread

Survival rate

Number of
individuals

0

1

4

0.9800

365,464

50

2

3

0.8916

121,066

65

3

2

0.7613

35,983

75

4

1

0.7083

23,247

Total

545,760
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Table 5  Descriptive analytics
based on the number of medical
conditions

Table 6  Descriptive analytics
based on the occupation

Number of medical
conditions cutoff

M-score

Survival rate

Number of
individuals

0

1

0.9552

279,883

1

2

0.9389

193,072

3

3

0.8625

61,400

5

4

0.7358

10,712

7

5

0.7128

693

Total

545,760

Occupation categories

O-score

Risk of spread

Number of
individuals

At home

1

1

109,432

Online

2

1

54,448

Student or teacher

3

3

218,446

Essential

4

5

163,434

Total

545,760

four was assigned to this group. In the dataset, there were 365,464 individuals in this
age group. Using the model, the survival rate for this group was calculated to be at
0.9800. The same calculations were made for the other age groups.
In Table 5, the population sample is organized based on the number of medical conditions of individuals. The first row represents all individuals that have no
medical conditions. An M-score of 1 was assigned to this group. In the dataset, there
were 279,883 individuals in this group. The second row represents the individuals
with 1 or 2 medical conditions; the third row represents individuals with 3 or 4 medical conditions, and so on. Using the model, the survival rate for all groups of medical conditions was calculated.
Table 6 shows the population sample organized based on occupation. The population sample (as discussed earlier, see Table 3) was classified into four categories:
at-home individuals, online workers, students and teachers, and essential workers.
A-score of 1 was assigned for at-home individuals. These individuals have a minimum risk of spreading the infection; therefore, a risk value of 1 was assigned. The
same lowest risk value of 1 was assigned to those working from home during the
pandemic. As for students and teachers that are considered a medium risk of spreading the virus, a risk value of 3 was assigned, and to essential workers that have the
highest risk, a risk value of 5 was assigned.
In Table 7, a small sample of the dataset is presented to demonstrate how the proposed model was used to calculate the risk of spreading the disease and the mortality rate for individuals.
For example, suppose an individual in the first row is 27 years old, has
no medical conditions, and is an essential worker. Using “vlookup” Excel
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0

0

0

99400080158 13

99400080148 34

99400080138 33

2

0

99400080178 41

99400080168 48

0

2

0

99400080208 7

99400080198 78

0

99400080218 41

99400080188 38

1

1

2

99400080248 61

99400080238 68

0

99400080258 16

99400080228 12

0

1

99400080278 25

99400080268 42

4

1

99400080298 58

99400080288 41

Student or
teacher-

Onllne

At home

At home

Essential

Online

At home

Student or
teachet

Student or
teacher-

Student or
teacher

At home

Student or
teacher

Student or
teacher

At home

At home

Essential

At home

Essential

Essential

1

1

1

1

1

1

4

1

1

1

3

2

1

1

1

1

2

1

1

1

1

1

2

2

1

1

1

2

2

2

1

2

1

2

3

1

1

3

2

1

1

4

2

1

3

3

3

1

3

3

1

1

4

1

4

4

4

4

4

4

4

4

1

4

4

4

2

3

4

4

4

4

3

4

4

1

0

0

50624012333 27

99500564132 41

A·score M score O score Risk of
spread based
on age

Table 7  The risk of spreading and mortality rate calculation for each individual

Individual ID Age MedCond Occupation

3

1

1

1

5

1

1

3

3

3

1

3

3

1

1

s

1

5

5

3.5000

2.5000

2.5000

2.5000

4.5000

2.5000

1.0000

3.5000

3.5000

3.5000

1.5000

3.0000

3.5000

2.5000

2.5000

4.SOOO

2.0000

4.5000

4.5000

Risk of spread Average
spread risk
based on
occupation

0.019991

0.019991

0.019991

0.019991

0.019991

0.019991

0.291694

0.019991

0.019991

0.019991

0.238724

0.108395

0.019991

0.019991

0.019991

0.019991

0.108395

0.019991

0.019991

Mortality
based on
age

0.0447650

0.0447650

0.0447650

0.0447650

0.0611171

0.0611171

0.0447650

0.0447650

0.0447650

0.0611171

0.0611171

0.0611171

0.0447650

0.0611171

0.0447650

0.0611171

0.1374919

0.0447650

0.0447650

Mortality
based on
condition

0.0324

0.0324

0.0324

0.0324

0.0406

0.0406

0.1682

0.0324

0.0324

0.0406

0.1499

0.0848

0.0324

0.0406

0.0324

0.0406

0.1229

0.0324

0.0324

Average
mortality
rate

COVID‑19 vaccine distribution: exploring strategic…
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functions, A (age)-score of 1 to this person, M (medical condition)-score of 1, and O
(occupation)-score of 4 were assigned. Similarly, the individual’s risk of spreading
the virus is 4 based on age (see Table 4) and 5 based on occupation (see Table 6).
Thus, the average risk is 4.5. The mortality rate based on the individual’s age is
1–0.98001 = 0.01999 (see Table 4), and the mortality rate based on the number of
medical conditions is 1–0.955235 = 0.044765 (see Table 5). Thus, the mortality rate
for this individual is 0.0324.
Table 8 shows the initial values of the model parameters that we used in our illustration. It is assumed that the available doses of vaccines are less than the number of
individuals who need vaccination; specifically, 54,576 vaccines can only cover 10%
of the total number of individuals (545,760). It is also assumed that CDC or state
government guidelines require that individuals older than 65 years of age and those
with three or more medical conditions must be vaccinated as soon as possible.
Figure 1 presents a screenshot of the objective function, constraints, and decision variables. The model has a total of 80 binary decision variables and six nonbinary deviational variables. As mentioned earlier, there are three priorities, which,
for illustration purposes, were assigned an initial value P1 = P2 = P3 = 5. The figure
also shows the (aforementioned) constraints: three deviational constraints (2), (3),
and (4), and one system (5) constraint. The initial values of the decision variables
are zero.
4.2 GP model solutions
To show the efficiency and sensitivity of the proposed prototype model, three scenarios were run. In the base scenario, equal priorities were used to verify the model’s feasibility and identify and explain the solution. Then, two additional scenarios
were tried. Scenario 1 prioritized avoiding the risk of spreading the virus, and Scenario 2 prioritized the goal of minimizing the mortality rate.
4.2.1 Base scenario: equal priorities vaccination program
This is the scenario when goal priorities are the same (P1 = P2 = P3). This solution where the priorities are given equal weights is shown in Fig. 2. As shown, the
Table 8  Model parameters
% of vaccine availability

10%

Number of available vaccines

54576.00

Number of individuals to be vaccinated

545760.00

Number of vaccinated individuals

0.00

Number of subgroups with individuals that are older than 65 and with more than 3 medical
conditions to be vaccinated

26912.00

Number of vaccinated individuals older than 65 and with more than 3 medical conditions

0.00

Total amount of spread risk

0.00

Total amount of mortality rate

0.00
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Fig. 1  Decision variables, objective function, and constraints

model suggests that everyone older than 65 and those with more than three medical conditions must be vaccinated. This requirement satisfies the first priority goal
(s1− = 0.00) that meets the CDC guidelines. One possible explanation of this “unexpected compliance” is that Solver, in a search for continuous improvement, tends to
start at this feasible solution and moves away from that only if it finds a better solution, which is unlikely since the three priorities have equal weights. Therefore, the
rest of the available vaccines are distributed “randomly, without a specific goal” to
other groups, since the goal priorities are the same.
As expected, the solution in Fig. 2 will not change if the first priority was
enhanced, since the constraint is already satisfied. The other priorities, the spread
of the virus (s2+ = 57.00), and the mortality rate (s3+ = 6.37) are not achieved. This
result demonstrates the proposed model’s ability to evaluate whether certain vaccination guidelines will help achieve the vaccination program goals regarding mortality rate, herd immunity, and hospital utilization.
4.2.2 Scenario 1: minimizing the virus spread risk
In this scenario, to make sure that the virus spread risk is minimized, the value
of P2 was increased to 1000. As shown in Fig. 3, the vaccination policy recommended in this scenario lowered the positive deviation of the spread of
risk constrain from 57.00 to11.50, a reduction of 79.82%. A very significant
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Fig. 2  Initial solution with equal GP priorities

improvement. This solution offers another positive result as a “byproduct.” The
mortality rate is also reduced from 6.37 to 1.34, that is, a reduction of 78.96%.
However, this solution indicates that not all the subgroups could not be reached:
those aged above 65 or those with more than three medical conditions since the
negative deviation is not zero (s1− = 16,373.00).
4.2.3 Scenario 2: minimizing the mortality rate
As mentioned in the previous section, increasing the weight on the second priority already contributed significantly to the reduction of the mortality rate.
As such, the values of P1 = 1, P2 = 1000, and P3 = 1000 are kept. As shown in
Fig. 4, there is a further reduction in the mortality rate. s3+ value drops to 1.03
in this scenario from 6.37 in the base scenario, consisting of 83.83% reduction.
This solution represents the best scenario regarding the mortality rate. However,
it should be noted that according to this scenario, the goal of vaccinating the
individuals according to age or the number of medical conditions is less achievable since the “Age and Medical Condition” constraint’s negative deviation
increases from zero in the base scenario to 17,476.00. The same is true regarding the “Risk of Spread” goal where the positive deviation increased from 11.50
to 12.00.
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Fig. 3  Solution with GP priorities (P1 = 1, P2 = 1000, P3 = 1)

5 Discussion and conclusion
As COVID-19 vaccines have become available, government officials are struggling
with their efforts to administer the vaccines in the population’s arms as quickly
as possible. At the time this paper was being prepared, the proportion of the US
population fully vaccinated was about 66.14% (with states ranging from 50.71% to
92.84%) (Johns Hopkins University 2021). Timely distribution of the vaccines is the
key to achieving herd immunity, and there is a sense of urgency as new strains of
the virus that are extremely contagious have evolved. Besides the speed of delivery,
the state-run vaccination programs have multiple goals. These goals include reducing the number of new infections, minimizing the mortality rate, while at the same
time following the CDC guidelines regarding people’s age, medical conditions, and
occupation. This paper offers a decision-making tool that allows federal and local
government officials and healthcare practitioners to determine the optimum COVID
vaccine distribution based on age, medical condition, and occupation. The proposed
GP model seeks to satisfy three objective criteria: prioritize the elderly and those
with medical conditions, minimize the virus spread, and minimize the mortality
rate. The model used binary values, and its solution indicates which specific set of
population subgroups must be vaccinated at a given time.
The first step in the modeling process is identifying the cutoff points for each
group. This paper used cutoff points based on the COVID-19-related information
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Fig. 4  Solution with GP Priorities (P1 = 1, P2 = 1000, P3 = 1000)

available at the time of this study. However, specific criteria and their cutoff points
should be determined based on the unique conditions of the area (city, state, country,
or region) in collaboration with medical personnel and healthcare policy makers.
The key contribution of this research is that it proposes a dynamic model that allows
the decision-makers to change the objective criteria (beyond grouping on age,
medical condition, and occupation), create additional or fewer subgroups based on
changes in the environment, and adjust variables as the vaccination program moves
throughout different stages. This paper illustrated the model and its efficiency using
a large dataset of real-world COVID-19, which includes more than a half-million
individuals. The paper demonstrates that the proposed GP model can significantly
improve the outcome of a vaccination program, especially for decreasing the mortality rate.
The specific results of this study should not be used to recommend or provide
guidelines on vaccination programs as the prototype model assumed a certain set
of environmental conditions, which could be different from those of real-world scenarios or environments. However, the greatest advantage of the proposed GP model
is that it demonstrates how a continuous evaluation of the priorities of various goals
to determine and adjust the vaccine distribution plans can be done based on the fluid
and dynamic environmental conditions. Furthermore, this dynamic GP model can
be adjusted or refined for different levels (national, regional, state, city/county, etc.)

13

COVID‑19 vaccine distribution: exploring strategic…

and for different timelines (e.g., the first dose, second dose, etc.). The vaccination
campaign is now well under way in many countries. However, the proposed model
can be used by countries at different stages of vaccination, for the distribution of
new vaccines for new COVID variants, and for the preparation of future pandemics. The 0–1 GP model can accurately predict the subgroups of individuals to be
vaccinated. The real efficacy of the model is its capability for dynamic change and
scalability based on the unique conditions of the decision environment. The model
can also adjust the optimization criteria according to the goals or subgoals of the
vaccination campaign’s priorities. Another easy modification to the model is changing the decision variable requirements from binary to continuous. In such cases, the
solutions would indicate what proportion of individuals in each subgroup needs to
be vaccinated, instead of determining whether a subgroup must be vaccinated or not.
Finally, because each pandemic has its own characteristics, a decision support
model should be flexible enough for assigning appropriate priorities to different
population segments depending on changing environmental conditions or vaccine
distribution logistics requirements. For example, the Spanish Flu of 1918–1920
was deadly for young people as compared to COVID-19 which has been especially
dangerous to the older generation. The proposed model is capable of handling such
challenges in managing vaccine distribution for future pandemics.

References
Apple Q, Azimi T, Cordina J (2020) COVID-19 vaccine: are US consumers ready? McKinsey & Company (Dec. 10). Retrieved from https://www.mckinsey.com/industries/healthcare-systems-andse
rvices/our-insights/covid-19-vaccine-are-consumers-ready/. Accessed December 29, 2020
Arenas M, Bilbao A, Caballero R, Gómez T, Rodríguez MV, Ruiz F (2002) Analysis via goal programming of the minimum achievable stay in surgical waiting lists. J Oper Res Soc 53(4):387–396.
https://doi.org/10.1057/palgrave.jors.2601310
Asllani A, Lari A (2015) Using goal programming to increase the efficiency of marketing campaign. J Int
Interdiscip Bus Res 2(1):53–68
Asllani A, Halstead D (2015) A multi-objective optimization approach using the RFM model in direct
marketing. Acad Mark Stud J 19(3):49–61
Brem A, Viardot E, Nylund P (2021) Implications of the Coronavirus (COVID-19) outbreak for innovation: which technologies will improve our lives? Technol Forecast Soc Chang. https://doi.org/10.
1016/j.techfore.2020.120451
Charnes A, Cooper WW, Ferguson R (1955) Optimal estimation of executive compensation by linear
programming. Manage Sci 1(2):138–151. https://doi.org/10.1287/mnsc.1.2.138
Colapinto C, Jayaraman R, Marsiglio S (2017) Multi-criteria analysis with goal programming in engineering, management and social sciences: a state-of-the-art review. Ann Oper Res 251:7–40. https://
doi.org/10.1007/s10479-015-1829-1
Daly C S, Rolander N (2021) Stockholm endures 100% spike in covid cases as third wave hits. Bloomberg. March 3. Retrieved from https://www.bloomberg.com/news/articles/2021-03-03/stockholm-hit-
by-100-spike-in-virus-infections-in-just-3-weeks. Accessed on March 4, 2021.
Davis NG, Klepak P, Liu Y, Jit PKM, CMMID COVID-19 Working Group, Eggo RM (2020) Agedependent effects in the transmission and control of COVID-19 epidemics. Nat Med 26:1205–1211.
https://doi.org/10.1038/s41591-020-0962-9
Devezas T (2020) The struggle SARS-CoV-2 vs. homo sapiens: why the earth stood still and how will
it keep moving on. Technol Forecast Soc Chang 160:1–5. https://doi.org/10.1016/j.techfore.2020.
120264

13

A. Asllani, S. Trimi
euro.who.int. (2020) Factsheet - vulnerable populations during COVID-19 response - addressing vulnerability upfront in the WHO European region. Oct. 2020. Retrieved from https://www.euro.who.
int/en/media-centre/sections/fact-sheets/2020/factsheetvulner able-populations-during-covid-19-
response-addressing-vulnerability-upfront-inthe-who-european-region-october-2020. Accessed on
December 7, 2020
Fda.gov (2021) FDA issues emergency use authorization for third COVID-19 vaccine. Feb. 27. Retrieved
from https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorizat
ion-third-covid-19-vaccine. Accessed on April 5, 2021
Gillespie C (2020) COVID-19 vaccine priority groups: CDC panel recommends who should get the vaccine first. Health. Dec. 3. Retrieved from: https://www.health.com/condition/infectious-diseases/
coronavirus/covid-19-vaccinepriority-groups. Accessed on December 14, 2020
Hovav S, Herbon A (2017) Prioritizing high-risk sub-groups in a multi-manufacturer vaccine distribution
program. Int J Logist Manag 28(2):311–331. https://doi.org/10.1108/IJLM-12-2015-0227
Ignizio JP (1976) Goal programming and extensions. Lexington Books, Lexington, MA
Ioannidis PA, Axfors C, Contolopoulos-Ioannidis DG (2020) Population-level COVID19 mortality risk
for non-elderly individuals overall and for non-elderly individuals without underlying diseases in
pandemic epicenters. Environ Res. https://doi.org/10.1016/j.envres.2020.109890
Johns Hopkins University (2022) Corona Virus Resource Center. Retrieved from https://coronavirus.jhu.
edu/. Accessed on May 25, 2022
Jones D, Tamiz M (2010) Case study: application of goal programming in health care. Retrieved
1/4/2021. https://doi.org/10.1007/978-1-4419-5771-9_8.
Jones D, Tamiz M (2002) Goal programming in the period 1990–2000 In Book: multiple criteria optimization: state of the art annotated bibliographic surveys. Springer, Newyork
Jung C-Y, Park H, Kim DW, Choi YJ, Kim SW, Chang TI (2020) Clinical characteristics of asymptomatic
patients with COVID-19: a nationwide cohort study in South Korea. Int J Infect Dis 99:266–268.
https://doi.org/10.1016/j.ijid.2020.08.001
Kendall KE, Lee SM (1980a) Improving perishable product inventory management using goal programming. J Oper Manag 1(2):77–84. https://doi.org/10.1016/0272-6963(80)90015-7
Kendall KE, Lee SM (1980b) Formulating blood rotation policies with multiple objectives. Manage Sci
26(11):1145–1157. https://doi.org/10.1287/mnsc.26.11.1145
Kim SR, Nam SH, Kim Y-R (2020) Risk factors on the progression to clinical outcomes of COVID-19
patients in South Korea: using national data. Int J Environ Res Public Health. 17(23):8847
Leatherby L (2021) As variants have spread, progress against the virus in US has stalled. New York
Times, Newyork
Lee SM (1972) Goal programming for decision analysis. Auerback, Philadelphia
Lee SM, Trimi S (2021) Convergence innovation in the digital age and in the COVID-19 pandemic crisis.
J Bus Res 123:14–22
Lovelace Jr. B (2020) FDA panel recommends approval of Pfizer’s Covid vaccine for emergency use.
CNBC: Health and Science. Dec. 10. Retrieved from https://www.cnbc.com/2020/12/10/pfizer-
covid-vaccine-fda-panel-recommendsapproval-for-emergency-use.html. Accessed on December 17,
2020
Martin T Yoon D (2020) How South Korea successfully managed coronavirus. The Wall Street Journal
edition. Sept. 25. https://www.wsj.com/articles/lessons-from-south-koreaon-how-to-manage-covid-
11601044329.
Miller S G, Edwards E (2020). FDA grants emergency authorization to Moderna’s Covid-19 vaccine.
NBC Health News. Dec. 18. Retrieved from https://www.nbcnews.com/health/health-news/fda-
grants-emergency-authorizationmoderna-s-covid-19-vaccine-n1251553. Accessed on December 20,
2020
Morbidity and mortality weekly report (CDCMMWR). Retrieved from https://www.cdc.gov/mmwr/
volumes/69/wr/mm695152e2.htm. Accessed on December 27, 2020
Mukherjee T (2020) COVID-19 patient pre-condition dataset. Kaggle. Aug .Retrieved from https://www.
kaggle.com/tanmoyx/covid19-patient-precondition-dataset?select=covid.csv.
Muller AL, McNamara M, Sinclair D (2020) Why does COVID-19 disproportionately affect older people? Aging. 12(10):9959–9981
Nigma B, Nigma A, Jain R, Dodia S, Arora N, Annapp B (2021) COVID-19: automatic detection from
X-ray images by utilizing deep learning methods. Exp Syst Appl. https://doi.org/10.1016/j.eswa.
2021.114883

13

COVID‑19 vaccine distribution: exploring strategic…
Nikolopoulos K, Punia S, Schafers A, Tsinopoulos C, Vasilakis C (2021) Forecasting and planning during a pandemic: COVID-19 growth rates, supply chain disruptions, and governmental decisions.
Euro J Oper Res. 290(1):99–115
Pollock AM, Lancaster J (2020) Asymptomatic transmission of Covid-19. BMJ 371:m4851. https://doi.
org/10.1136/bmj.m4851
Rho H J, Brown H, Fremstad S (2020) A basic demographic profile of workers in frontline industries.
Center for Economic and Policy Research (CEPR). Apr. 7. Retrieved from https://cepr.net/a-basic-
demographic-profile-of-workers-in-frontline-industries
Romero C (1991) Handbook of critical issues in goal programming. Pergamon Press, Oxford
Sainz-Pardo JL, Valero J (2021) COVID-19 and other viruses: holding back its spreading by massive testing. Expert Syst Appl. https://doi.org/10.1016/j.eswa.2021.115710
Schniederjans MJ (1995) Goal programming methodology and applications. Kluwer, Boston
Silal SP (2021) Operational research: a multidisciplinary approach for the management of infectious disease in a global context. Eur J Oper Res 291(3):929–934. https://doi.org/10.1016/j.ejor.2020.07.037
Spiegelhalter D (2020) Use of “normal” risk to improve understanding of dangers of Covid-19. BMJ.
https://doi.org/10.1136/bmj.m3259
Yu J, Cao Z, Lai Q (2015) To alleviate the Ebola virus epidemic diffusion. Prog Appl Math 8(2):15–29.
https://doi.org/10.3968/6871
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps
and institutional affiliations.

13

